Long intergenic non-protein coding RNA 1509 (LINC01509)

Long intergenic non-protein coding RNA 1509 (LINC01509) is a member of the long non-coding RNAs (lncRNAs), specifically classified as a long intergenic non-protein coding RNA (lincRNA)[1][3]. Unlike protein-coding genes, LINC01509 does not encode a protein but functions as an RNA molecule involved in regulating a variety of cellular processes[3]. LINC01509 can regulate target gene expression by interacting with promoter regions, recruiting transcription factors, and modulating alternative splicing events[3]. It is differentially expressed between cancer and normal tissue, correlating with cancer progression and stage, particularly in prostate adenocarcinoma (PRAD), suggesting it may be involved in oncogenic processes or serve as a biomarker[3]. While lincRNAs as a class have been implicated as potential therapeutic targets or biomarkers in cancer, there is no direct evidence that drugs currently target LINC01509, nor is it categorized as a receptor, enzyme, transporter, or classical therapeutic target[5][3][2].

Other names

LINC0150909q31.2